首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1544666

居家照护测试市场、机会、成长动力、产业趋势分析与预测，2024-2032

Home Care Testing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月11日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于产品发布激增及其与健康应用的集成，家庭护理测试市场规模预计从 2024 年到 2032 年将以 6.8% 的复合年增长率扩大。

为了满足不断增长的需求，该公司正在推出与各种健康应用程式无缝连接的新型家庭测试设备。这些技术进步使个人能够在舒适的家中更轻鬆、更精确地监测自己的健康状况。这些进步不仅促进了即时健康跟踪，还为个性化护理铺平了道路，刺激了该行业的进一步创新和采用。例如，2023 年 10 月，PHASE Scientific Americas 推出了 INDICAID Health™ 家用测试套件以及数位健康平台。这项最新产品旨在与数位工具集成，使用户能够在家中有效地进行测试并管理自己的健康状况。

整个市场分为产品类型、测试类型、样品、配销通路和区域。

根据产品类型，预计从 2024 年到 2032 年，测试面板领域的家庭护理测试市场价值将大幅增长。为此，该公司正在製作先进的测试面板，使个人能够在家中进行各种诊断。这些测试面板富含多种生物标记物，可提供全面的健康见解，简化使用者的状况监测和健康追踪。

预计到 2032 年，线上药局配销通路领域的家庭护理测试行业规模将以复合年增长率大幅增长。分销的数位化转变不仅简化了家庭护理测试产品的采购，还提高了使用者的便利性和效率。为了进一步提高可及性，线上药局正在采用即时库存更新、个人化推荐和直接送货上门等功能。

从地区来看，由于人口老化和慢性病的增加，预计 2024 年至 2032 年间欧洲家庭护理测试市场规模将出现显着的复合年增长率。随着慢性病变得越来越普遍，对定期家庭检测和管理的需求不断增加。作为回应，公司正在微调他们的居家护理测试产品，确保使用者拥有轻鬆进行健康监测所需的工具。此外，随着复杂测试技术的进步以及与数位健康平台的增强集成，该地区的个人能够更好地主动管理自己的健康。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性病盛行率增加
  - 对现场检测的需求不断增长
  - 产品技术进步
- 产业陷阱与挑战
  - 成本高
成长潜力分析
监管环境
2023 年定价分析
技术景观
波特的分析
PESTEL分析
未来市场趋势
差距分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032

主要趋势
条
卡式磁带
测试板
中游
浸卡
其他产品类型

第 6 章：市场估计与预测：按测试类型，2021 - 2032

主要趋势
传染病
糖尿病和葡萄糖
爱滋病
怀孕
胆固醇和三酸甘油酯
泌尿道感染
其他测试类型

第 7 章：市场估计与预测：按样本，2021 - 2032 年

主要趋势
血
尿
唾液
其他样品

第 8 章：市场估计与预测：按配销通路划分，2021 - 2032 年

主要趋势
零售药局
医院药房
网路药局
其他分销管道

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Abbott
ACON Laboratories, Inc.
Ascensia Diabetes Care Holdings AG
BD
bioLytical Laboratories Inc.
BioSure
Cardinal Health
Chembio Diagnostics, Inc
F. Hoffmann-La Roche Ltd.
LifeScan IP Holdings, LLC
MP BIOMEDICALS
Nova Biomedical
OraSure Technologies, Inc.
Quidel Corp.
SA Scientific Ltd
Siemens Healthcare GmbH
Sterilab Services

简介目录

Product Code: 10201

Home Care Testing Market size is projected to expand at a 6.8% CAGR from 2024 to 2032, due to the surge in product launches and their integration with health applications.

In response to the rising demands, companies are unveiling new home testing devices that seamlessly interface with various health applications. These technological strides empower individuals to monitor their health with greater ease and precision, all from the comfort of their homes. Such advancements not only facilitate real-time health tracking but also pave the way for personalized care, spurring further innovation and adoption in the sector. For instance, in October 2023, PHASE Scientific Americas rolled out the INDICAID Health(TM) at-home test kits, coupled with a digital health platform. This latest offering, designed to integrate with digital tools, empowers users to efficiently conduct tests and manage their health from home.

The overall market is segregated into product type, test type, sample, distribution channel, and region.

Based on product type, the home care testing market value from the test panel segment is estimated to rise at a substantial rate from 2024 to 2032. This surge is attributed to the rising demand for diverse health solutions. In response, companies are crafting advanced test panels, allowing individuals to conduct a wide array of diagnostics from home. These test panels, enriched with multiple biomarkers, offer holistic health insights, simplifying condition monitoring and wellness tracking for users.

Home care testing industry size from the online pharmacies distribution channel segment is anticipated to grow at a substantial CAGR through 2032. This uptick is largely due to the increasing demand for easy consumer access. The digital shift in distribution not only simplifies the acquisition of home care testing products but also enhances user convenience and efficiency. To further bolster accessibility, online pharmacies are adopting features like real-time inventory updates, personalized recommendations, and direct-to-door delivery.

Regionally, the Europe home care testing market size is projected to depict a notable CAGR between 2024 and 2032, on account of the aging population and the rise in chronic diseases. As chronic conditions become more prevalent, there is a heightened demand for regular at-home testing and management. In response, companies are fine-tuning their home care testing products, ensuring users have the tools they need for effortless health monitoring. Furthermore, with advancements like sophisticated testing technologies and enhanced integration with digital health platforms, individuals in the region are better equipped to manage their health proactively.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic diseases
  - 3.2.1.2 Growing demand for point of care testing
  - 3.2.1.3 Technological advancements in the products
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High costs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pricing analysis, 2023
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Strip
5.3 Cassette
5.4 Test panel
5.5 Midstream
5.6 Dip card
5.7 Other product types

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Infectious disease
6.3 Diabetes and glucose
6.4 HIV
6.5 Pregnancy
6.6 Cholesterol and triglycerides
6.7 Urinary tract infection
6.8 Other test types

Chapter 7 Market Estimates and Forecast, By Sample, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Blood
7.3 Urine
7.4 Saliva
7.5 Other samples

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Retail pharmacies
8.3 Hospital pharmacies
8.4 Online pharmacies
8.5 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa